Literature DB >> 15902519

Infliximab as monotherapy in giant cell arteritis.

Imad Uthman, Nadim Kanj, Samir Atweh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15902519     DOI： 10.1007/s10067-005-1115-8

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

1.  Treatment of longstanding active giant cell arteritis with infliximab: report of four cases.

Authors:  F Cantini; L Niccoli; C Salvarani; A Padula; I Olivieri
Journal:  Arthritis Rheum       Date:  2001-12

2.  Experience with infliximab (anti-TNF alpha monoclonal antibody) as monotherapy for giant cell arteritis.

Authors:  A P Andonopoulos; N Meimaris; D Daoussis; A Bounas; G Giannopoulos
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

3.  Infliximab efficiency and failure.

Authors:  A P Rozin
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

4.  The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.

Authors:  Imad Uthman; Kamel Mroueh; Thuraya Arayssi; Fuad Nasr; Abdul-Fattah Masri
Journal:  Semin Arthritis Rheum       Date:  2004-06       Impact factor: 5.532

5.  Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity.

Authors:  C M Weyand; J W Fulbright; G G Hunder; J M Evans; J J Goronzy
Journal:  Arthritis Rheum       Date:  2000-05

6.  Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis.

Authors:  M Field; A Cook; G Gallagher
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

7.  A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis.

Authors:  José Hernández-Rodríguez; Ana García-Martínez; Jordi Casademont; Xavier Filella; María-José Esteban; Alfonso López-Soto; Joaquim Fernández-Solà; Alvaro Urbano-Márquez; Josep M Grau; Maria C Cid
Journal:  Arthritis Rheum       Date:  2002-02

8.  Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients.

Authors:  G Nesher; M Sonnenblick; Y Friedlander
Journal:  J Rheumatol       Date:  1994-07       Impact factor: 4.666

9.  Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis.

Authors:  J Hernández-Rodríguez; M Segarra; C Vilardell; M Sánchez; A García-Martínez; M J Esteban; C Queralt; J M Grau; A Urbano-Márquez; A Palacín; D Colomer; M C Cid
Journal:  Rheumatology (Oxford)       Date:  2003-12-16       Impact factor: 7.580

Review 10.  Giant-cell arteritis and polymyalgia rheumatica.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Ann Intern Med       Date:  2003-09-16       Impact factor: 25.391
  10 in total
  7 in total

Review 1.  New indications for biological therapies.

Authors:  Mariagrazia Catanoso; Nicolò Pipitone; Luca Magnani; Luigi Boiardi; Carlo Salvarani
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

2.  The use of biological therapy in refractory rheumatic diseases other than rheumatoid arthritis: experience at a tertiary care center in Lebanon.

Authors:  Khaled M Musallam; Thurayya Arayssi; Ali T Taher; Nadim Kanj; Imad Uthman
Journal:  Rheumatol Int       Date:  2008-12-04       Impact factor: 2.631

Review 3.  The treatment of giant cell arteritis.

Authors:  J Alexander Fraser; Cornelia M Weyand; Nancy J Newman; Valérie Biousse
Journal:  Rev Neurol Dis       Date:  2008

Review 4.  Diagnosis and treatment of giant cell arteritis.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Michele Bertoni; Carlo Salvarani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2007-10       Impact factor: 1.372

Review 6.  Biologic Therapy for the Treatment of Giant Cell Arteritis.

Authors:  Rochella A Ostrowski; Melissa R Bussey; Rodney Tehrani; Walter Jay
Journal:  Neuroophthalmology       Date:  2014-04-02

Review 7.  Unmet Needs in the Pathogenesis and Treatment of Vasculitides.

Authors:  Francesco Muratore; Giulia Pazzola; Alessandra Soriano; Nicolò Pipitone; Stefania Croci; Martina Bonacini; Luigi Boiardi; Carlo Salvarani
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.